Thorax

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study.  75:808-811. 2020

Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traits.  75:520-527. 2020

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.  73:414-421. 2018

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.  72:318-326. 2017

Latent tuberculosis infection screening and treatment in HIV: Insights from evaluation of UK practice.  72:180-182. 2017

Biomechanical CT metrics are associated with patient outcomes in COPD.  72:409-414. 2017

Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.  71:1082-1090. 2016

β-Blockers are associated with a reduction in COPD exacerbations.  71:8-14. 2016

Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia.  70:41-47. 2015

Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: Authors' response.  69:1147-1148. 2014

Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.  69:409-414. 2014

Progress in cystic fibrosis and the CF Therapeutics Development Network.  67:882-890. 2012

Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease.  67:399-406. 2012

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.  67:12-18. 2012

Genome-wide association study of smoking behaviours in patients with COPD.  66:894-902. 2011

Intrapulmonary shunting associated with sildenafil treatment in a patient with idiopathic pulmonary arterial hypertension.  66:1097-1098. 2011

PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice.  66:788-796. 2011

Pneumocystis jirovecii in pleural infection: A nucleic acid amplification study.  66:450-451. 2011

Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: Role of Hsp90 and Hsp70.  65:346-353. 2010

Gastro-oesophageal reflux and aspiration in patients with advanced lung disease.  64:167-173. 2009

Authors' response.  63:1026. 2008

Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.  63:301-305. 2008

Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.  63:154-159. 2008

Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade.  63:147-153. 2008

Authors' response.  63:1027. 2008

Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis.  63:935-936. 2008

Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.  62:964-968. 2007

Author's reply [6].  62:924. 2007

Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection.  61:791-794. 2006

Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.  61:716-721. 2006

A&E department: A missed opportunity for diagnosis of TB? [4].  61:364-365. 2006

Genotypic variation in Pneumocystis jirovecii isolates in Britain.  60:679-682. 2005

Pneumocystis jirovecii infection.  59:731-733. 2004

Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii (5) [multiple letters].  59:83-84. 2004

Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: A prospective study.  58:594-597. 2003

Changes in nitric oxide synthase activity in the porcine lung after birth.  53. 1998

Nebulisers for patients with HIV infection and AIDS.  52. 1997

Alveolar lymphocytes and macrophages are an important source of HIV-1 in patients with AIDS.  51. 1996

Genotypic variants of HIV-1 from peripheral blood and lung of AIDS patients.  51. 1996

Authors' Reply.  50:1227. 1995

Erratum: Inadvertent duplicate publication (Thorax (1995) 50 (191-200)).  50:1228. 1995

Erratum: Inadvertent duplicate publication (Thorax (1995) 50 (191-200)).  50:1228. 1995

Interstitial pneumonitis in patients infected with the human immunodeficiency virus.  50:1141-1146. 1995

New developments in the pulmonary diseases affecting HIV infected individuals.  50:294-302. 1995

Pneumocystis carinii pneumonia.  50:191-200. 1995

Role of the human immunodeficiency virus within the lung.  50:567-576. 1995

Community acquired lobar pneumonia in patients with HIV infection and AIDS.  49:367-368. 1994

Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1.  48:204-207. 1993

Histologically atypical Pneumocystis carinii pneumonia.  48:996-1001. 1993

Bronchopulmonary Kaposi's sarcoma in patients with AIDS.  47:721-725. 1992

Pneumocystis carinii pneumonia.  47:305-314. 1992

Arterial desaturation in HIV positive patients undergoing sputum induction.  46:449-451. 1991

AIDS and the lung: 5 - Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus.  45:62-65. 1990

Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage (I: Reply).  45:302. 1990

Granulomatous Pneumocystis carinii pneumonia in a patient with the acquired immunodeficiency syndrome.  45:769-771. 1990

Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.  45:140-146. 1990

Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage.  44:554-558. 1989

Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.  44:559-564. 1989

Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.  44:565-569. 1989

Infectious complications after heart transplantation.  38:822-828. 1983

Technique, complications, and climncal value of endomyocardial biopsy in patients with heterotopic heart transplants.  37:727-731. 1982

Empyema after internal jugular catheterisation in rheumatoid arthritis.  36:958-959. 1981

Management of oesophageal perforation associated with benign stricture and hiatus hernia by oesophagoplasty and fundoplication.  36:541-542. 1981

Pharmacological and hypothermic inhibition of metabolism during myocardial ischaemia.  35:75. 1980

Collagen diseases as a cause of constrictive pericarditis.  33:368-371. 1978

Incidence of postoperative infection and role of antibiotic prophylaxis in pulmonary surgery.  33:130. 1978

Conservative surgery for bronchial adenomata.  31:44-48. 1976

Transplantation of the heart and both lungs. I. Historical review..  24:383-390. 1969

Transplantation of the heart and both lungs. II. Experimental cardiopulmonary transplantation..  24:391-398. 1969